Citadel Advisors LLC

SEC CIK: 0001423053
Latest filing: Sep 1, 2026

SEC filings (opens in a new tab)

ETTX holding history

Entasis Therapeutics Holdings Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ETTX overview All 13F holders of ETTX Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of ETTX by Citadel Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−10,197−100.0%	Sold out	Holders
Q4 2021	10,197	$22.0K	<0.1%	+10,197	New	Holders
Q2 2021	0	$0	0.0%	−68,574−100.0%	Sold out	Holders
Q1 2021	68,574	$147.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.